An additional analysis of publically available gene expression data of BM plasma cells from MM counterparts evidenced significantly a higher transcriptional level of TRPV2 in plasma cells of patients with shorter Event-Free Survival (EFS, <24 months) compared to patients with longer EFS (≥24 months) [22]. This evidence concerns the gene TRPV2 and Miyoshi myopathy.